Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.
about
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice GuidelineNo Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison's Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These ConditionsDehydroepiandrosterone and age-related cognitive decline.Evo-devo of human adolescence: beyond disease models of early puberty.A new look at the 5alpha-reductase inhibitor finasteride.Clinical Assessment of Tribulus terrestris Extract in the Treatment of Female Sexual DysfunctionChronic fatigue syndrome: an endocrine disease off limits for endocrinologists?Management of adrenocortical insufficiency with continuous subcutaneous hydrocortisone infusion: long-term experience in three patients.The Association between Chronic Widespread Musculoskeletal Pain, Depression and Fatigue Is Genetically Mediated.Hormonal determinants and effect of ER22/23EK glucocorticoid receptor gene polymorphism on health status deterioration in the participants of the Mataró Ageing StudyCase records of the Massachusetts General Hospital. Case 16-2013. A 12-year-old girl with irritability, hypersomnia, and somatic symptoms.Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial.Endocrine and Metabolic Pathways Linked to Keratoconus: Implications for the Role of Hormones in the Stromal MicroenvironmentRehabilitation in endocrine patients: a novel psychosomatic approach.Proteomic profiling in schizophrenia: enabling stratification for more effective treatment.Long-acting hydrocortisone for glucocorticoid replacement therapy.Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trialTherapy of adrenal insufficiency: an update.Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters.Global and Targeted Metabolomics Evidence of the Protective Effect of Chinese Patent Medicine Jinkui Shenqi Pill on Adrenal Insufficiency after Acute Glucocorticoid Withdrawal in RatsDehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement.Resolution of Suicidal Ideation With Corticosteroids in a Patient With Concurrent Addison's Disease and Depression.Quality of life in Addison's disease--the case for DHEA replacement.Subjective health status in Norwegian patients with Addison's disease.Effect of dehydroepiandrosterone supplementation on fatty acid and hormone levels in patients with X-linked adrenoleucodystrophy.DHEA(S)--a novel marker in Cushing's disease.Effect of DHEAS on skeletal muscle over the life span: the InCHIANTI study.How do you avoid and treat steroid side effects?Androgen status in healthy premenopausal women with loss of libido.Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects.Effects of dehydroepiandrosterone sulphate (DHEAS) replacement on insulin action and quality of life in hypopituitary females: a double-blind, placebo-controlled study.Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency.Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status.Dehydroepiandrosterone and Erectile Function: A Review.
P2860
Q26772152-976D16D7-CA8A-4CEE-974C-1D5E01BC106BQ33658675-B723E171-9D3C-43F1-9E88-873CF1ABD880Q33692587-0841CB8D-ACC1-4AC9-B2E0-86E9FFCF3253Q34341825-1550D9FF-D382-4F98-B360-B28EE6E359E6Q34546591-F6E83CAB-BE9E-472F-922B-F9DE3A81C85CQ34667443-B4A57DA7-DA72-4E5D-8308-E6640A00D217Q35592461-AF02CA24-EC05-42FA-89BD-CCFFA1E4E547Q35786396-A67F4F8E-CDA7-48FB-8896-B2E661137A3EQ35850501-3FF70EEA-B713-407B-BBC5-AE9839392981Q35916506-63988C0B-9FF3-475A-8379-04585628406DQ36616193-C77C454F-303B-4965-BC8E-3BE6D9EE4719Q36731206-B7544188-5AD1-4459-94C6-F24E250D35DBQ36881839-701B950C-543D-4A9D-A7E5-9E8104F56FA0Q36961365-78A7776E-723A-48AB-B37A-7C8BE4F4ECD5Q36998471-B0C0FEE2-1662-4B1C-876C-9E75C71C6CAEQ37050120-68382024-6A5F-4169-B47F-64806A61BCF2Q37300547-02AB9AF0-AE0F-415D-89C8-41DDB26ECA80Q37311106-F0B2E2C6-AFC2-43FB-9989-F38B6F310B56Q38062413-102CE0CF-ADE4-4B65-9373-994EA16D4C32Q40521614-47EF9FCE-0FB0-4FA3-A5E4-B15153F948D2Q41689358-6D549A2B-E3C0-476A-B39A-39F8609BFD54Q42601336-0BA3A5AE-EC27-4BC5-BB6F-E21C9317A47CQ42689936-B25C195E-1F78-47B1-A4C2-D228596148A4Q44006163-F4C01642-C30C-438D-9537-1B178C0152EFQ44006170-66E2328F-D000-4D68-9A40-7B45D1D39BBAQ44597106-7DE7F8AD-DDFB-4876-A625-867273B57189Q44603194-5F3CE818-AACF-4AED-80F3-BDB4052AB047Q44881299-EFA4D395-67C2-4C5C-94F5-DD0AD3C0F3F8Q46347476-FD216217-9DC1-49BC-8A2A-4047B8277390Q46446727-60979B86-749E-4A82-B38D-23684A4502D5Q46951277-F25FA68D-6E75-45F9-A33A-EB355E027948Q48468072-3620C682-7F1E-4CDB-84E3-26C389572118Q48770628-A94E4B29-C3C8-42FA-8CCB-46173C3CB564Q51766426-4577FC52-A09A-453D-A988-98177A5B20ACQ53682523-EB0DB900-B677-43DC-AF78-2772F9BB3161
P2860
Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Improvement in mood and fatigu ...... andomized, double blind trial.
@en
Improvement in mood and fatigu ...... andomized, double blind trial.
@nl
type
label
Improvement in mood and fatigu ...... andomized, double blind trial.
@en
Improvement in mood and fatigu ...... andomized, double blind trial.
@nl
prefLabel
Improvement in mood and fatigu ...... andomized, double blind trial.
@en
Improvement in mood and fatigu ...... andomized, double blind trial.
@nl
P2093
P356
P1476
Improvement in mood and fatigu ...... andomized, double blind trial.
@en
P2093
Chatterjee VK
Gurnell EM
Prevost AT
Richards C
P304
P356
10.1210/JC.85.12.4650
P407
P577
2000-12-01T00:00:00Z